1. Home
  2. IRTC vs BLCO Comparison

IRTC vs BLCO Comparison

Compare IRTC & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRTC
  • BLCO
  • Stock Information
  • Founded
  • IRTC 2006
  • BLCO 1853
  • Country
  • IRTC United States
  • BLCO Canada
  • Employees
  • IRTC N/A
  • BLCO N/A
  • Industry
  • IRTC Medical/Dental Instruments
  • BLCO Ophthalmic Goods
  • Sector
  • IRTC Health Care
  • BLCO Health Care
  • Exchange
  • IRTC Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • IRTC 4.9B
  • BLCO 4.9B
  • IPO Year
  • IRTC 2016
  • BLCO 2022
  • Fundamental
  • Price
  • IRTC $169.12
  • BLCO $14.93
  • Analyst Decision
  • IRTC Strong Buy
  • BLCO Hold
  • Analyst Count
  • IRTC 11
  • BLCO 11
  • Target Price
  • IRTC $162.64
  • BLCO $15.80
  • AVG Volume (30 Days)
  • IRTC 577.0K
  • BLCO 943.3K
  • Earning Date
  • IRTC 07-31-2025
  • BLCO 07-30-2025
  • Dividend Yield
  • IRTC N/A
  • BLCO N/A
  • EPS Growth
  • IRTC N/A
  • BLCO N/A
  • EPS
  • IRTC N/A
  • BLCO N/A
  • Revenue
  • IRTC $657,227,000.00
  • BLCO $4,891,000,000.00
  • Revenue This Year
  • IRTC $25.11
  • BLCO $7.10
  • Revenue Next Year
  • IRTC $16.65
  • BLCO $5.50
  • P/E Ratio
  • IRTC N/A
  • BLCO N/A
  • Revenue Growth
  • IRTC 22.37
  • BLCO 8.81
  • 52 Week Low
  • IRTC $55.92
  • BLCO $10.45
  • 52 Week High
  • IRTC $172.00
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • IRTC 66.93
  • BLCO 64.22
  • Support Level
  • IRTC $152.05
  • BLCO $14.24
  • Resistance Level
  • IRTC $168.09
  • BLCO $14.80
  • Average True Range (ATR)
  • IRTC 4.98
  • BLCO 0.44
  • MACD
  • IRTC 0.49
  • BLCO 0.05
  • Stochastic Oscillator
  • IRTC 83.13
  • BLCO 92.72

About IRTC iRhythm Technologies Inc.

iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: